47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,3 | 0,3 | 0,3 | 4,8 |
Gross profit (loss) | 0,4 | 0,3 | 0,4 | 38,7 |
EBITDA | 0,3 | 0,3 | 0,3 | -0,7 |
Short time liabilities | 1,6 | 1,7 | 1,9 | 6,7 |
Other operating costs | 0,1 | 0,1 | 0,1 | 30 |
Equity capital | 1,3 | 1,6 | 1,9 | 20,5 |
Operating profit (EBIT) | 0,3 | 0,3 | 0,2 | -1,5 |
Assets | 3 | 3,4 | 3,9 | 15,3 |
Net profit (loss) | 0,3 | 0,2 | 0,3 | 38,7 |
Cash | 0 | 0 | 0 | 53,8 |
Net income from sale | 8 | 8,8 | 9,8 | 11,4 |
Liabilities and provisions for liabilities | 1,7 | 1,8 | 2 | 10,7 |
Working assets | 2,9 | 3,2 | 3,7 | 14,3 |
Other income costs | 0,1 | 0 | 0 | 47,4 |
Depreciation | 0 | 0 | 0 | 13 |
% | % | % | p.p. | |
Profitability of capital | 24,4 | 14,8 | 17 | 2,2 |
Equity capital to total assets | 44,5 | 46,7 | 48,9 | 2,2 |
Gross profit margin | 5,1 | 3,3 | 4,1 | 0,8 |
EBITDA Margin | 4 | 3 | 2,7 | -0,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 74 | 72 | 69 | -3 |
Current financial liquidity indicator | 1.779349446296692 | 1.861223578453064 | 1.9941426515579224 | 0,1 |
Net dept to EBITDA | -0.06781845539808273 | -0.04300743341445923 | -0.06663492321968079 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane